Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study

1. Younes, A.
2. Brody, J.
3. Carpio, C.
4. Lopez-Guillermo, A.
5. Ben-Yehuda, D.
6. Ferhanoglu, B.
7. Nagler, A.
8. Ozcan, M.
9. Avivi, I.
10. Bosch, F.
11. Caballero Barrigón, M.D.
12. Hellmann, A.
13. Kuss, B.
14. Ma, D.D.F.
15. Demirkan, F.
16. Yağci, M.
17. Horowitz, N.A.
18. Marlton, P.
19. Cordoba, R.
20. Wrobel, T.
21. Buglio, D.
22. Streit, M.
23. Hodkinson, B.P.
24. Schaffer, M.
25. Alvarez, J.
26. Ceulemans, R.
27. Balasubramanian, S.
28. de Jong, J.
29. Wang, S.-S.
30. Fourneau, N.
31. Jurczak, W.
32. Mostrar todos los/as autores/as +